Femynor Kit
Product Images NDC 69238-1551

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Femynor (NDC 69238-1551). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister For Inserts (Femynor 1)

An instructional diagram for the Femynor oral contraceptive kit showing a weekly pill schedule with day labels from Sunday to Saturday. It includes guidance for both Sunday starters and Day 1 starters. The diagram indicates 4 weeks of pills, with the first 3 weeks displayed as empty circles and the 4th week as filled green circles. Arrows show the direction to take pills from left to right each week. Storage instructions at 20° to 25°C and protection from light are noted.*

FDA Label Image

Norgestimate Formula (Femynor 2)

Chemical structure of norgestimate displayed as a molecular diagram, showing the arrangement of atoms and bonds in the compound.*

FDA Label Image

Ethinyl Estradiol (Femynor 3)

Chemical structure of Ethinyl Estradiol, a component of Femynor (norgestimate and ethinyl estradiol). The diagram shows the steroidal framework with hydroxyl groups and a characteristic ethynyl group.*

FDA Label Image

Chart (Femynor 4)

A vertical arrow chart illustrating contraceptive effectiveness by pregnancy rates per 100 women per year. The top section, labeled 'Fewer Pregnancies,' lists contraceptives like implants, injections, intrauterine devices, and sterilization with fewer than 1 pregnancy. Below, birth control pills, skin patch, and vaginal ring with hormones show slightly higher pregnancy rates. Condoms and diaphragm are next, followed by no sex during fertile days, spermicide, and withdrawal with 10 to 20 pregnancies. At the bottom, 'No birth control' corresponds to 85 or more pregnancies with 'More Pregnancies.'*

FDA Label Image

Blister (Femynor 5)

An instructional diagram for Femynor (norgestimate and ethinyl estradiol) oral contraceptive tablets, showing a 28-tablet kit organized by day and week. The diagram indicates the starting point for both Sunday and Day 1 starters with circles representing pills for each day of the week over four weeks, with the fourth week's pills highlighted in green. Arrows guide the direction to take the pills from left to right each week. Additional labeling includes storage instructions and distribution information by Amneal Pharmaceuticals LLC.*

FDA Label Image

Carton (Femynor 6)

Packaging label for Femynor kit containing norgestimate and ethinyl estradiol tablets USP. The dosage strength is 0.25 mg of norgestimate and 0.035 mg of ethinyl estradiol. The kit contains 1 blister pack with 28 tablets. Labeler is Amneal Pharmaceuticals NY LLC. The label includes medication details and usage warnings, with the NDC 69238-1551 visible.*

FDA Label Image

Blister Card (Femynor 7)

Femynor kit contains norgestimate and ethinyl estradiol tablets, USP, 0.25 mg/0.035 mg strength, with 28 tablets arranged by day of the week for a 4-week cycle. The label shows dosage days Sunday through Saturday, includes storage instructions (20 to 25°C, protect from light), and indicates distribution by Amneal Pharmaceuticals LLC with manufacturing in Germany.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.